联合术前血小板/淋巴细胞及中性粒细胞/淋巴细胞比率与肿瘤相关因素预测胃癌患者淋巴结转移

Combination of preoperative platelet/lymphocyte and neutrophil/lymphocyte rates and tumor-related factors to predict lymph node metastasis in patients with gastric cancer.

作者信息

Pang Wenyang, Lou Neng, Jin Cancan, Hu Changyuan, Arvine Chandoo, Zhu Guangbao, Shen Xian

机构信息

Department of Gastrointestinal Surgery, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China.

出版信息

Eur J Gastroenterol Hepatol. 2016 May;28(5):493-502. doi: 10.1097/MEG.0000000000000563.

Abstract

OBJECTIVE

Lymph node (LN) metastasis is widely accepted as a poor prognosis indicator in patients with gastric cancer. An accurate preoperative prediction of LN status is of crucial importance for the planning treatment. The aim of the present study was to assess the predictive value of the preoperative platelet/lymphocyte (PLR) and neutrophil/lymphocyte rates (NLR) on the LN metastasis in gastric cancer patients and to develop a new preoperative score system to predict LN metastasis.

PATIENTS AND METHODS

A total of 492 operable patients with gastric cancer were enrolled in our study. The clinical utility of the PLR and NLR was evaluated by receiver operating characteristic (ROC) curves. The logistic analysis was used to identify the independent parameters associated with LN metastasis. Then, a score system including those independent parameters that can be detected preoperatively was established, which was also tested by an ROC curve.

RESULTS

The ideal cutoff values for predicting LN metastasis were 1.59 for NLR and 155.67 for PLR according to the ROC curve. Multivariate analyses showed that both PLR and NLR are significantly associated with LN metastasis independent of depth of invasion, lymphatic invasion, macroscopic type, and tumor size. The area under the ROC curve of the score system was 0.830 (95% confidence interval 0.782-0.878), showing a reliable ability to evaluate the status of nodal involvement.

CONCLUSION

Preoperative PLR and NLR are useful biomarkers to predict LN metastasis and the score system in our study may serve as a reliable instrument to predict LN metastasis in gastric cancer patients.

摘要

目的

淋巴结(LN)转移被广泛认为是胃癌患者预后不良的指标。准确术前预测LN状态对于治疗方案规划至关重要。本研究旨在评估术前血小板/淋巴细胞(PLR)和中性粒细胞/淋巴细胞比率(NLR)对胃癌患者LN转移的预测价值,并开发一种新的术前评分系统来预测LN转移。

患者与方法

本研究共纳入492例可手术的胃癌患者。通过受试者工作特征(ROC)曲线评估PLR和NLR的临床效用。采用逻辑分析确定与LN转移相关的独立参数。然后,建立了一个包含术前可检测到的独立参数的评分系统,并通过ROC曲线进行测试。

结果

根据ROC曲线,预测LN转移的理想临界值NLR为1.59,PLR为155.67。多因素分析表明,PLR和NLR均与LN转移显著相关,且独立于浸润深度、淋巴浸润、大体类型和肿瘤大小。评分系统的ROC曲线下面积为0.830(95%置信区间0.782 - 0.878),显示出评估淋巴结受累状态的可靠能力。

结论

术前PLR和NLR是预测LN转移的有用生物标志物,本研究中的评分系统可作为预测胃癌患者LN转移的可靠工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9fe/4892768/a4a96ca3a67c/meg-28-493-g002.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索